Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Artificial Intelligence–Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer

Published:2021-04-22 Issue:12 Volume:27 Page:3422-3431
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Williams Christopher J.M.^ORCID,Seligmann Jenny F.^ORCID,Elliott Faye,Shires Michael,Richman Susan D.^ORCID,Brown Sarah,Zhang Liping,Singh Shalini,Pugh Judith^ORCID,Xu Xiao-Meng,Muranyi Andrea^ORCID,Guetter Christoph^ORCID,Lorsakul Auranuch,Kurkure Uday,Zhao Zuo,Martin Jim,Wang Xingwei,Nguyen Kien^ORCID,Liu Wen-Wei,Yan Dongyao,West Nicholas P.^ORCID,Barrett Jennifer H.^ORCID,Barnes Michael,Bai Isaac,Seymour Matthew T.^ORCID,Quirke Philip^ORCID,Shanmugam Kandavel

Funder

Yorkshire Cancer Research

Roche Tissue Diagnostics

Cancer Research UK

Amgen

UKRI | Innovate UK

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Big Data and Colorectal Cancer: the Revolution will be Personalised;Clinical Oncology;2024-04

2. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis;BMC Cancer;2023-11-16

3. Towards Multiomics-Based Dissection of Anti-EGFR Sensitivity in Colorectal Cancer;Clinical Cancer Research;2023-08-18

4. Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer;Clinical Cancer Research;2023-06-26

5. Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance;Oncogene;2022-10-06